How Much Did Groundwork BioAg Raise?
Funding & Key Investors

Groundwork BioAg has secured $29M in total capital, with its most recent financing round bringing in $18M. This significant backing underscores the company's pivotal role in advancing bioagriculture and its potential for substantial growth in the sustainable farming sector.

What is Groundwork BioAg?

Groundwork BioAg
ManufacturingChemicals & Related ProductsBusiness Services

Groundwork BioAg is a global bioagriculture company dedicated to enhancing agricultural productivity, sustainability, and profitability through the natural power of mycorrhizal fungi. The company is at the forefront of expanding regenerative agriculture practices, offering innovative solutions that improve soil health and crop yields. Their approach leverages biological inputs to create a more resilient and environmentally sound food system, positioning them as a key player in the agtech industry.

How much funding has Groundwork BioAg raised?

Groundwork BioAg has raised a total of $29M across 2 funding rounds:

2021

Unspecified

$11M

2022

Series B

$18M

Unspecified (2021): $11M with participation from ProDelta Holding, Future Foodways, and Ibex Investors

Series B (2022): $18M led by HSBC Global Asset Management, ICV Ventures, BASF Venture Capital, Middleland Capital, and Climate Innovation Capital

Key Investors in Groundwork BioAg

HSBC Global Asset Management

HSBC Global Asset Management is a prominent financial institution likely focused on large-scale investments and asset management within the agriculture technology sector.

BASF Venture Capital

BASF Venture Capital is the corporate venture arm of BASF, a global leader in chemicals, likely investing in agtech innovations that align with their strategic interests in sustainable agriculture and crop solutions.

Middleland Capital

Middleland Capital is a venture capital fund specializing in the food and health sectors, with a clear focus on agtech and innovative solutions that promote sustainability and drive change in agriculture.

What's next for Groundwork BioAg?

With substantial enterprise-level funding and a recent strategic investment, Groundwork BioAg is poised for accelerated expansion. This capital infusion is expected to fuel further research and development into novel fungal-based agricultural solutions, enhance global market penetration, and scale production capabilities. The company's trajectory suggests a strong focus on solidifying its leadership in the bioagriculture market and driving the adoption of sustainable farming methods worldwide.

See full Groundwork BioAg company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

ManufacturingMedical Devices & EquipmentRetailApparel & Accessories RetailTextiles & Apparel
ManufacturingTest & Measurement EquipmentAppliances
FurnitureManufacturingArchitecture, Engineering & DesignConstruction
Industrial Machinery & EquipmentManufacturingAutomotive Parts

Frequently Asked Questions Regarding Groundwork BioAg Financial Insights

What are the most recent funding rounds that Groundwork BioAg has completed, and what were the funding rounds?
Groundwork BioAg has recently completed 2 funding rounds: Series B on Aug 18, 2022, Unspecified on May 12, 2021.
What is the total amount of funding Groundwork BioAg has raised to date?
Groundwork BioAg has raised a total of $29M in funding to date.
How many funding rounds has Groundwork BioAg completed?
Groundwork BioAg has completed 2 funding rounds.
How much funding did Groundwork BioAg raise in its most recent funding round?
Groundwork BioAg raised $18M in its most recent funding round.
Who are the lead investors in Groundwork BioAg's latest funding round?
The lead investor in Groundwork BioAg's latest funding round was HSBC Global Asset Management. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Groundwork BioAg's history?
The largest funding round in Groundwork BioAg's history was $18M.
See more information about Groundwork BioAg